Directori de persones
Luis Brieva Ruiz

Luis Brieva Ruiz

Grau: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/E-8505-2019

Publicacions

  • Porcel, I; Nos, C; Rovira, A; Tintore, M; Arevalo, MJ; Aymerich, X; Borras, C; Brieva, L; Rio, J; Montalban, X

    Symbol Digit Modalities Test: an alternative to paced auditory serial addition test for the multiple sclerosis functional composite

    MULTIPLE SCLEROSIS JOURNAL 11 70-71. .

  • Sanmarti, FX; Brieva, L; Mas, MJ; Hanckiewich, C; Malaga, I

    Epilepsy with EEG paroxysmal discharges during slow sleep and arousal: a sub-type of nocturnal frontal lobe epilepsy or a new epileptic syndrome?

    Epilepsia 46 53-53. .

  • Espejo, C; Brieva, L; Ruggiero, G; Rio, J; Montalban, X; Martinez-Caceres, EM

    IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 10 630-635. .

    [doi:10.1191/1352458504ms1094oa]

  • Porcel, J; Brieva, L; Tintore, M; Sanchez-Betancourt, A; Arevalo, M; Junque, G; Guardia, J; Montalban, X

    Inhibition processes in multiple sclerosis patients

    MULTIPLE SCLEROSIS JOURNAL 10 119-119. .

  • Rio, J; Nos, C; Bonaventura, I; Arroyo, R; Genis, D; Sureda, B; Ara, JR; Brieva, L; Martin, J; Saiz, A; Lopez, FS; Prieto, JM; Roquer, J; Dorado, JF; Montalban, X

    Corticosteroids, ibuprofen, and acetaminophen for IFN beta-1a flu symptoms in MS - a randomized trial

    Neurology 63 525-528. .

  • Sastre-Garriga, J; Comabella, M; Brieva, L; Rovira, A; Tintore, M; Montalban, X

    Decreased MMP-9 production in primary progressive multiple sclerosis patients.

    MULTIPLE SCLEROSIS JOURNAL 10 376-380. .

    [doi:10.1191/1352458504ms1058oa]

  • Pericot, I; Brieva, L; Tintore, M; Rio, J; Sastre-Garriga, J; Nos, C; Montalban, X

    Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 9 256-259. .

    [doi:10.1191/1352458503ms905oa]

  • Ruiz, LB; Gomez, RB; de la Rosa, AT; Berra, MM

    Crossed bucofacial apraxia

    MEDICINA CLINICA 120 718-718. .

  • Brieva, L; Rio, J; Montalban, X

    Primary progressive multiple sclerosis

    REVISTA DE NEUROLOGIA 35 1074-1080. .

  • Martinez-Caceres, EM; Espejo, C; Brieva, L; Pericot, I; Tintore, M; Saez-Torres, I; Montalban, X

    Expression of chemokine receptors in the different clinical forms of multiple sclerosis.

    MULTIPLE SCLEROSIS JOURNAL 8 390-395. .

    [doi:10.1191/1352458502ms841oa]

  • Saez-Torres, I; Brieva, L; Espejo, C; Barrau, MA; Montalban, X; Martinez-Caceres, EM

    Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse.

    Autoimmunity 35 45-50. .

    [doi:10.1080/08916930290005927]

  • Martinez-Caceres, EM; Barrau, MA; Brieva, L; Espejo, C; Barbera, N; Montalban, X

    Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

    CLINICAL AND EXPERIMENTAL IMMUNOLOGY 127 165-171. .

    [doi:10.1046/j.1365-2249.2002.01725.x]

Projectes

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO